全球避孕藥具市場（2023-2030）：按產品（口服藥/注射劑）和分銷渠道（零售藥房/醫院）劃分的規模、份額、增長分析和預測

全球避孕藥具市場規模預計將從2021年的280.9億美元增長到2022年的299.9億美元，預測期內復合年增長率為6.5%，到2030年將達到505.9億美元。預計將增長到1000萬美元美元。

由於多種因素，全球避孕市場預計將增長。 性傳播疾病（STD）患病率的增加以及無法獲得避孕藥具和設備的女性人數的增加預計將推動市場增長。 據世界衛生組織（WHO）統計，全球有超過11億女性需要計劃生育，約2.7億女性避孕需求未得到滿足。 預防意外懷孕和提高用戶意識的有針對性的計劃預計將進一步推動市場增長。

另一方面，對避孕副作用（例如胃部不適、腹脹、頭暈和體重增加）的擔憂可能會阻礙市場增長。 此外，新興市場不孕不育的普遍存在和性教育方面的差距可能會阻礙全球避孕市場的增長。 儘管存在這些挑戰，由於計劃生育以及實施提高認識和預防方案的需求增加，預計在預測期內對避孕藥具的需求將會增長。

避孕藥具在降低意外懷孕率方面發揮著重要作用，特別是在窮人和低收入人群中。 避孕藥具的使用為降低孕產婦死亡率和不安全墮胎做出了重大貢獻，並應對全球人口不斷增長和性病發病率上升的問題。

各國政府和非政府組織正在加緊努力，通過執行嚴格的避孕措施來應對人口增長和性傳播疾病。 生殖健康研究所和計劃生育基金會等各種組織發起了有關正確避孕的公眾意識計劃。

技術進步是避孕市場勢頭強勁的一個突出趨勢，其中數字避孕是最新的創新。 數字節育在線跟蹤您的月經週期並確定您有懷孕風險的天數。 這種數字方法為女性管理不孕症和避免意外懷孕提供了一種新的便捷方式。

在本報告中，我們研究了全球避孕藥具市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律和監管環境、市場規模轉變和預測以及各種細分市場和地區。編制了單獨的細分、競爭格局、主要參與者的概況等。

內容

執行摘要

調查方法

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 驅動程序
  • 機會
  • 制約因素
  • 任務

主要市場洞察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 知識產權分析
• 貿易分析
• 啟動分析
• 原材料分析
• 創新矩陣
• 管道產品分析
• 宏觀經濟指標
• 主要投資分析
• 關鍵成功因素
• 爭用程度

市場動態與展望

• 市場動態
  • 驅動程序
  • 機會
  • 制約因素
  • 任務
• 監管狀況
• 波特的分析
• Skyquest 對未來顛覆的特殊洞察

全球避孕市場：按產品

• 市場概況
• 口服避孕藥
• 注射避孕藥
• 局部避孕藥

全球避孕市場：按分銷渠道劃分

• 市場概況
• 零售藥店
• 醫院藥房
• 診所
• 在線
• 公眾/非政府組織

全球避孕市場：按地區

• 市場概況
• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲

競爭格局

• 排名前 5 名的公司比較
• 主要公司的市場定位
• 各大公司的招聘策略
• 關鍵成功策略
• 近期市場活動
• 主要公司的市場份額

主要公司簡介

• Pfizer Inc.
• Bayer AG
• Merck &Co., Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Allergan plc
• Mithra Pharmaceuticals SA
• Afaxys, Inc.
• Reckitt Benckiser Group plc
• CooperSurgical, Inc.
• Agile Therapeutics, Inc.
• Novartis International AG
• GlaxoSmithKline plc
• Johnson &Johnson
• Merck KGaA
• HLL Lifecare Limited
• Church &Dwight Co., Inc.
• Mayer Laboratories, Inc.
• The Female Health Company
• Okamoto Industries, Inc.

Global Contraceptive Drugs Market size was valued at USD 28.09 billion in 2021 and is poised to grow from USD 29.99 billion in 2022 to USD 50.59 billion by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030)

The global contraceptive drugs market is anticipated to experience growth driven by several factors. Increasing incidences of sexually transmitted diseases (STDs) and a rising number of women with no access to contraceptive drugs and devices are expected to boost market growth. According to the World Health Organization, over 1.1 billion women of reproductive age globally require family planning, and approximately 270 million women have unmet contraceptive demand. Targeted programs to prevent unplanned pregnancies and raise user awareness are projected to further drive market growth.

However, the market also faces challenges. Concerns about the side effects of contraceptive drugs, such as stomach upset, bloating, dizziness, and weight gain, could impede market growth. Additionally, infertility prevalence and disparities in sex education in developed countries are potential obstacles to the growth of the global contraceptive drugs market. Despite these challenges, the demand for contraceptive drugs is likely to grow due to the increasing need for family planning and the implementation of awareness and prevention programs during the forecast period.

Segments covered in this report:

Global contraceptive drugs market is segmented on the basis of product, distribution channel and region. On the basis of product, global market is segmented into, oral contraceptive pills, injectable contraceptives and topical contraceptives. On the basis of distribution channel, global market is segmented into, retail pharmacy, hospital pharmacy, clinics, online channel and public channel & NGOs. On the basis of region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

Preventing Unwanted Pregnancies: Contraceptive drugs play a crucial role in reducing the prevalence of unintended pregnancies, especially among poor and low-income populations who often rely on traditional methods. Their use contributes significantly to lowering maternal deaths and unsafe abortions, addressing the increasing global population and STD rates.

Government and NGO Initiatives: Governments and non-governmental organizations have intensified efforts to address population growth and STDs by implementing strict birth control measures. Various organizations, such as reproductive health institutes and family planning foundations, have launched public awareness programs on proper contraception.

Restraint

The global contraceptive drugs market faces hindrances due to the adverse effects of long-term birth control pill use. Prolonged consumption, typically over ten years, may result in side effects like headaches, bleeding, and nausea. Furthermore, medications containing oestrogen and progesterone pose an elevated risk of blood clots, potentially leading to heart attacks. These concerns about the safety of long-term use act as a restraint on the market's growth.

Market Trends

Technological advancements are a prominent trend gaining momentum in the contraceptive drugs market, with digital contraception being the latest innovation. Digital contraception involves tracking menstrual cycles online to determine days at risk for pregnancy. In March 2021, the Berlin-based femtech company Clu obtained FDA approval to market Clu Birth Control, an all-digital contraceptive relying on period monitoring data. This contraceptive function combines a user's menstrual cycle data with Clue's prediction algorithm to identify high or low-risk days for pregnancy. Users can then adjust their habits according to their risk tolerance. Clue recommends abstaining from intercourse or using additional forms of contraception, like condoms, during high-risk days. This digital approach offers a new and convenient way for women to manage their fertility and avoid unwanted pregnancies.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Contraceptive Drugs Market by Product

• Market Overview
• Oral contraceptive pills
• Injectable contraceptives
• Topical contraceptives

Global Contraceptive Drugs Market by Distribution Channel

• Market Overview
• Retail pharmacy
• Hospital pharmacy
• Clinics
• Online channel
• Public channel & NGOs

Global Contraceptive Drugs Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Female Health Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Okamoto Industries, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments